Ramon Varcoe retweeted
Ramon Varcoe (@RamonVarcoeMD) reflects on the wider impact of the results of the LIFE-BTK trial on CLTI treatment #TCT2023
Ramon Varcoe retweeted
nejm.org/doi/full/10.1056/NE…
This study represents a breakthrough for our patients. So grateful for the chance to help lead this trial with an amazing team. – at San Francisco, CA
In this fascinating interview, Dr Gary Roubin discusses the origins of interventional cardiology and peripheral vascular interventions, including the influence of his mentor Andreas Gruentzig.
podcasts.google.com/feed/aHR…
Ramon Varcoe retweeted
Dr. Andrew Holden & Prof. Ramon Varcoe (@RamonVarcoeMD) summarize our issue on SFA treatment that features global experts sharing the latest updates in above-the-knee interventions.
evtoday.com/articles/2022-se…
Ramon Varcoe retweeted
1/Today published in @JACCJournals is the 1st global consensus document on IVUS use for lower ext arterial & venous revasc. This document involved >40 international multidisciplinary experts in vascular disease & was led by a 12 person steering committee.
bit.ly/3A7bcTY
Ramon Varcoe retweeted
This expert review details the utility of intravascular ultrasound (IVUS) for the management of peripheral artery and venous disease, and provides contemporary examples and representative imaging to serve as a resource for the practising clinician. eurointervention.pcronline.c…
Ramon Varcoe retweeted
#cx2022 Ramon Varcoe discussing BlueLeaf valve technology from Intervene. Are we getting there with valve technology? Certainly food for thought.
The latest episode of Masters of Circulation is now out featuring Peter Schneider, Andrew Holden and myself interviewing Professor Roger Greenhalgh.
@VascularNews @EVToday @pschneidermd1
podcasts.apple.com/au/podcas…
Ramon Varcoe retweeted
DISFORM Classification System Developed for Angioplasty-Induced Femoropopliteal Dissection with commentary from investigator @RamonVarcoeMD. | @pschneidermd1 | @DrShannonThomas | @ehrin_armstrong evtoday.com/news/disform-cla…
Check out Episode 4 of Masters of Circulation. An excellent interview with @docmrjaff speaking with @PSchneiderMD Andrew Holden and myself about all things vascular.
podcasts.apple.com/au/podcas…
Ramon Varcoe retweeted
A trio of specialists in vascular surgery and interventional radiology recently launched a new podcast—‘Masters of Circulation’—with the aim of interviewing pioneers and leaders in the field of vascular intervention bit.ly/3bPT2Jh
@RamonVarcoeMD @pschneidermd1 #Vascular
In this fascinating interview, Marianne Brodmann tells us all about growing up on a farm in Austria...
podcasts.google.com/feed/aHR…
Great discussion by these three leading experts on a very important topic.
Dr. Ramon Varcoe (@RamonVarcoeMD) moderates discussion on outcomes in TASC C & D lesions, w/Drs. Herbert Aronow (@herbaronowMD), Darren Schneider (@VascularMD) & Sabine Steiner weighing in on available data & how they approach patients with severe disease. evtoday.com/articles/2021-se…
Ramon Varcoe retweeted
Did you know we have a Scopus indexed, open-access journal dedicated to venous, vascular and endovascular research and reviews?
Register now for access to FREE downloadable PDFs 📄 ow.ly/DjBX50GpUsd
@DrAndrewChoong @RKolluriMD @RamonVarcoeMD #vascular #VERJournal
In a new podcast called Masters of Circulation Andrew Holden, @pschneidermd1 and myself interview Frank Veith for Episode 1.
In a candid interview Dr Veith explores the early days of vascular surgery, the endovascular revolution, the struggles faced...
podcasts.google.com/feed/aHR…
...when embracing new technology, where the @VEITHsymposium came from and how it's evolved over the last 48yrs.
Fascinating insights into this eminent vascular leader.
@EVToday @VascularNews @hmpVDM @docmrjaff @roblookstein @VIVAPhysicians @VascularSVS @RKTvascular @VascularMD
Ramon Varcoe retweeted
Congratulations @krosenfieldMD, section head of Vascular Medicine and Intervention in the Division of Cardiology, on receiving the Mason F. Sones, Jr., MD Distinguished Service Award from the @SCAI for his contributions to Interventional Cardiology and Vascular Medicine.
Thanks @EVToday for taking a deep dive into our new meta-analysis and giving us the opportunity to provide a more detailed explanation as to why this and the 2018 study had such different results.
Updated Summary-Level Analysis of Paclitaxel-Coated Devices Shows No Evidence of Increased All-Cause Mortality Risk | @RamonVarcoeMD
evtoday.com/news/updated-sum…
New updated meta-analysis on paclitaxel and mortality published today.
Approximately 3x the patients at the 5-year follow as the 2018 JAHA study and very different results.
journals.sagepub.com/eprint/…














